Dr. David Fein

Dr. David Fein operates a physician-led wellness practice in Dallas, Texas, specializing in hormone optimization, medical weight loss, and evidence-based anti-aging interventions. With a 4.9-star rating across 28 Google reviews, the clinic has established a reputation for individualized metabolic and endocrine care in the North Dallas area. Dr. Fein, a board-certified physician, integrates pharmaceutical-grade peptide therapies with comprehensive lab analysis to address weight plateau, hormonal decline, and age-related metabolic dysfunction.

The clinic offers GLP-1 receptor agonist therapies including semaglutide and tirzepatide for patients seeking medically supervised weight management. Semaglutide, originally developed for type 2 diabetes, has demonstrated significant efficacy in reducing body weight by modulating appetite and insulin sensitivity. Tirzepatide, a dual GIP/GLP-1 receptor agonist, provides an additional mechanism of action that may benefit patients who require more robust glycemic control alongside weight reduction. Dr. Fein prescribes these peptides as part of structured programs that include baseline metabolic panels, body composition analysis, and ongoing dosage titration based on patient response and tolerance. Both therapies are administered via subcutaneous injection, with patients receiving detailed injection training and supply management during in-person consultations.

Testosterone replacement therapy forms a core component of the clinic's hormone optimization services. Dr. Fein evaluates male patients experiencing symptoms of hypogonadism—including fatigue, reduced libido, loss of muscle mass, and cognitive changes—through comprehensive hormone panels that assess total and free testosterone, estradiol, SHBG, and thyroid function. Treatment protocols may include testosterone cypionate injections, topical formulations, or combination approaches tailored to patient preference and pharmacokinetic profiles. The clinic monitors hematocrit, PSA, and lipid panels throughout therapy to ensure safety and efficacy. Female patients are also evaluated for hormonal imbalances related to perimenopause and menopause, with bioidentical hormone options available based on symptom presentation and lab findings.

Patients schedule in-person consultations at the Dallas clinic, where Dr. Fein conducts initial assessments that typically include medical history review, physical examination, and discussion of treatment goals. Follow-up visits are structured around lab intervals and clinical milestones, with most peptide therapy patients seen every 4-6 weeks during titration phases and quarterly once stable dosing is achieved. The practice emphasizes patient education, providing written protocols for medication administration, side effect management, and lifestyle modifications that support therapeutic outcomes. Patients receive direct access to clinical staff for questions between visits, and prescription fulfillment is coordinated through partnered compounding pharmacies that meet FDA and state board standards.

Dr. Fein's anti-aging strategies extend beyond hormone and peptide therapies to include nutritional optimization, supplement protocols, and metabolic health monitoring. The clinic uses advanced biomarker testing to assess inflammatory markers, insulin resistance, and cardiovascular risk factors that contribute to accelerated aging. Treatment plans are designed to address root causes rather than isolated symptoms, with interventions adjusted based on objective data from follow-up labs. For Dallas-area residents seeking a physician-directed approach to weight management, hormone health, and longevity medicine, Dr. Fein provides accessible, evidence-informed care with a focus on measurable clinical outcomes and patient safety.